X0206 3 2016-01-05 0 0001316175 Anthera Pharmaceuticals Inc ANTH 0001663298 Olson Charles V 25801 INDUSTRIAL BLVD SUITE B HAYWARD CA 94545 false true false false CHIEF TECHNOLOGY OFFICER Common Stock 7963 D Stock option (right to buy) 4.88 2023-05-17 Common Stock 43750 D Stock option (right to buy) 3.30 2024-03-25 Common Stock 922 D Stock option (right to buy) 2.89 2024-07-29 Common Stock 45000 D Stock option (right to buy) 1.61 2024-12-30 Common Stock 50000 D Stock option (right to buy) 9.48 2025-09-17 Common Stock 50000 D Stock option (right to buy) 3.70 2026-01-07 Common Stock 50000 D This stock option vests annually over four years. The vesting commencement date is March 25, 2013. This stock option is fully vested on March 25, 2017 and will expire on May 17, 2023. This stock option is immediately vested on the grant date of March 25, 2014. This stock option will expire on March 25, 2024. This stock option vests monthly over four years. The vesting commencement date is July 1, 2014. This stock option is fully vested on July 1, 2018 and will expire on July 29, 2024. This stock option vests monthly over four years. The vesting commencement date is December 30, 2014. This stock option is fully vested on December 30, 2018 and will expire on December 30, 2024. This stock option vests monthly over four years. The vesting commencement date is December 30, 2014. This stock option is fully vested on December 30, 2018 and will expire on September 17, 2025. This stock option vests monthly over four years. The vesting commencement date is January 7, 2016. This stock option is fully vested on January 7, 2020 and will expire on January 7, 2026. /s/ Charles V. Olson 2016-01-13